Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148796329> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2148796329 endingPage "68" @default.
- W2148796329 startingPage "60" @default.
- W2148796329 abstract "Abstract With the approval of second‐wave direct‐acting antivirals simeprevir, sofosbuvir and faldaprevir in 2014–2015, for genotype 1 hepatitis C, patients and doctors will have more treatment options. During a first period, these treatments will still be used with peginterferon and ribavirin. The second wave of IFN ‐based triple therapy will have benefits and risk. These treatments have the following advantages: higher efficacy with more patient candidates for a shorten treatment duration (12–24 weeks, instead of 48 weeks). These new treatments appear to have a better safety profile than first generation, with no additional increase in anaemia over peginterferon/ribavirin. Then, these treatments are to take for patients with a decrease in pill burden (these three direct‐acting antivirals are given orally one pill a day). Simeprevir and sofosbuvir may be approved in the US and E urope, in 2014, at the time this manuscript will be released. Approval of faldaprevir will follow. These direct‐acting antivirals with many others will hopefully be combined in future interferon‐free regimens. The goal of this review to summarize the results and safety of simeprevir, faldaprevir and sofosbuvir, to advise physicians and to inform patients on the benefits and risks of these second‐wave IFN ‐based regimens for HCV genotype infection." @default.
- W2148796329 created "2016-06-24" @default.
- W2148796329 creator A5009032052 @default.
- W2148796329 creator A5013246678 @default.
- W2148796329 date "2013-12-23" @default.
- W2148796329 modified "2023-10-15" @default.
- W2148796329 title "Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir" @default.
- W2148796329 cites W1985473671 @default.
- W2148796329 cites W1993274621 @default.
- W2148796329 cites W2009027044 @default.
- W2148796329 cites W2034641100 @default.
- W2148796329 cites W2043518660 @default.
- W2148796329 cites W2044547797 @default.
- W2148796329 cites W2060648165 @default.
- W2148796329 cites W2075833125 @default.
- W2148796329 cites W2077550422 @default.
- W2148796329 cites W2078251659 @default.
- W2148796329 cites W2101199621 @default.
- W2148796329 cites W2139953908 @default.
- W2148796329 cites W2142165617 @default.
- W2148796329 cites W2154658415 @default.
- W2148796329 cites W2156481634 @default.
- W2148796329 cites W252033410 @default.
- W2148796329 cites W3021771012 @default.
- W2148796329 cites W782262721 @default.
- W2148796329 doi "https://doi.org/10.1111/liv.12424" @default.
- W2148796329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24373080" @default.
- W2148796329 hasPublicationYear "2013" @default.
- W2148796329 type Work @default.
- W2148796329 sameAs 2148796329 @default.
- W2148796329 citedByCount "56" @default.
- W2148796329 countsByYear W21487963292014 @default.
- W2148796329 countsByYear W21487963292015 @default.
- W2148796329 countsByYear W21487963292016 @default.
- W2148796329 countsByYear W21487963292017 @default.
- W2148796329 countsByYear W21487963292018 @default.
- W2148796329 countsByYear W21487963292019 @default.
- W2148796329 countsByYear W21487963292020 @default.
- W2148796329 countsByYear W21487963292021 @default.
- W2148796329 countsByYear W21487963292022 @default.
- W2148796329 countsByYear W21487963292023 @default.
- W2148796329 crossrefType "journal-article" @default.
- W2148796329 hasAuthorship W2148796329A5009032052 @default.
- W2148796329 hasAuthorship W2148796329A5013246678 @default.
- W2148796329 hasBestOaLocation W21487963291 @default.
- W2148796329 hasConcept C126322002 @default.
- W2148796329 hasConcept C159047783 @default.
- W2148796329 hasConcept C2522874641 @default.
- W2148796329 hasConcept C2778390639 @default.
- W2148796329 hasConcept C2778986448 @default.
- W2148796329 hasConcept C2780040827 @default.
- W2148796329 hasConcept C3020491458 @default.
- W2148796329 hasConcept C71924100 @default.
- W2148796329 hasConcept C81603835 @default.
- W2148796329 hasConcept C98274493 @default.
- W2148796329 hasConceptScore W2148796329C126322002 @default.
- W2148796329 hasConceptScore W2148796329C159047783 @default.
- W2148796329 hasConceptScore W2148796329C2522874641 @default.
- W2148796329 hasConceptScore W2148796329C2778390639 @default.
- W2148796329 hasConceptScore W2148796329C2778986448 @default.
- W2148796329 hasConceptScore W2148796329C2780040827 @default.
- W2148796329 hasConceptScore W2148796329C3020491458 @default.
- W2148796329 hasConceptScore W2148796329C71924100 @default.
- W2148796329 hasConceptScore W2148796329C81603835 @default.
- W2148796329 hasConceptScore W2148796329C98274493 @default.
- W2148796329 hasIssue "s1" @default.
- W2148796329 hasLocation W21487963291 @default.
- W2148796329 hasOpenAccess W2148796329 @default.
- W2148796329 hasPrimaryLocation W21487963291 @default.
- W2148796329 hasRelatedWork W2063315423 @default.
- W2148796329 hasRelatedWork W2332034631 @default.
- W2148796329 hasRelatedWork W2406786677 @default.
- W2148796329 hasRelatedWork W2473540238 @default.
- W2148796329 hasRelatedWork W2522973404 @default.
- W2148796329 hasRelatedWork W2526193883 @default.
- W2148796329 hasRelatedWork W2598210959 @default.
- W2148796329 hasRelatedWork W2795717926 @default.
- W2148796329 hasRelatedWork W3025253505 @default.
- W2148796329 hasRelatedWork W4300554038 @default.
- W2148796329 hasVolume "34" @default.
- W2148796329 isParatext "false" @default.
- W2148796329 isRetracted "false" @default.
- W2148796329 magId "2148796329" @default.
- W2148796329 workType "article" @default.